



If Donald Trump or any Republican who might manage to win the White House and tries to dump the Affordable Care Act aka ObamaCare… it’s looking more and more like that’s not going to be easy to do.
According to reports, almost 8.3 million people have enrolled in ObamaCare plans, putting the administration well ahead of last year’s total at the same point in the sign-up season.
Federal health officials announced the latest figures on Tuesday, touting stronger-than-expected demand in December as healthcare customers race to find or switch plans ahead of the deadline to sign up for coverage beginning 2016.
The quicker pace likely indicates people are seeking to avoid the higher cost of being uninsured in 2016. People without insurance by tax season will face far steeper penalties, almost double the fee from the previous year, reports The Hill.
Of the 8.3 million sign-ups, about 2.4 million are new to the marketplace — a figure that is one-third higher than last year’s new total at the same distance from the deadline.
Significantly, this year’s sign-ups include 2.1 million people under age 35 — nearly double the number of young people enrolled during the same period last year.
“We’re excited in terms of what it means for health security and financial security. We’re excited about the fact that it does mean a younger risk pool, which is generally stronger,” Health and Human Services (HHS) Secretary Sylvia Mathews Burwell announced on a conference call with supporters Tuesday.
The growing diversity of the marketplace will be welcome news to health insurance companies, many of which remain worried that customers are older, and therefore costlier to cover, than they had originally expected.
Read the FULL report at The Hill.
article via eurweb.com





Iesha Thomas has been in and out of hospitals battling sickle cell disease since she was only 8 months old. This summer, 33-year-old Thomas became the first adult to be cured of sickle cell disease with a chemotherapy-free procedure at University of Illinois Hospital & Health Sciences System (UI Health), the University reported. Thomas is one of 12 adult patients cured of sickle cell disease as part of a clinical trial at UI Health that used a unique procedure for stem cell transplantation from healthy tissue matched from a sibling donor.
Findings from phase I/II of the clinical trial are published online in the journal Biology of Blood & Marrow Transplantation.
Stem cell transplants have been used for years as a means of possibly curing sickle cell disease. However, before the stem cell transplant could be completed patients would have to endure a taxing course of drugs to kill the cancer cells, otherwise known as chemotherapy.
The more traditional form of stem cell transplant uses chemotherapy to destroy the patient’s own bone marrow, which shuts down their immune system and makes them vulnerable to infections.
The new technique – first developed and performed at the National Institutes of Health campus in Maryland – eliminates the need for chemotherapy to prepare the patient to receive the transplanted cells and offers the prospect of cure for tens of thousands of adults suffering from sickle cell disease – many of them Black Americans.
According to the National Heart, Lung & Blood Institute (NIH), about 1 in 13 African American babies is born with sickle cell trait. About 1 in every 365 black children is born with sickle cell disease.
About 90 percent of the approximately 450 patients who have received stem cell transplants for sickle cell disease have been children. Chemotherapy has been considered too risky for adult patients, who are often more weakened than children by the disease.
“Adults with sickle cell disease are now living on average until about age 50 with blood transfusions and drugs to help with pain crises, but their quality of life can be very low,” says Dr. Damiano Rondelli, chief of hematology/oncology and director of the blood and marrow transplant program at UI Health, and corresponding author on the paper.
“Now, with this chemotherapy-free transplant, we are curing adults with sickle cell disease, and we see that their quality of life improves vastly within just one month of the transplant,” said Rondelli, who is also the Michael Reese Professor of Hematology in the UIC College of Medicine.

The chemo-free transplant performed by UI is described in a news release:
In the reported trial, the researchers transplanted 13 patients, 17 to 40 years of age, with a stem cell preparation from the blood of a tissue-matched sibling. Healthy sibling donor-candidates and patients were tested for human leukocyte antigen, a set of markers found on cells in the body. Ten of these HLA markers must match between the donor and the recipient for the transplant to have the best chance of evading rejection.
In a further advance of the NIH procedure, physicians at UI Health successfully transplanted two patients with cells from siblings who matched for HLA but had a different blood type.
In all 13 patients, the transplanted cells successfully took up residence in the marrow and produced healthy red blood cells. One patient who failed to follow the post-transplant therapy regimen reverted to the original sickle cell condition.
In Thomas’ case, her sister was a match and following the transplantation she no longer required blood transfusions.
Further research on this type of stem cell transplant is needed, but doctors are hopeful for what early trials show for adults.
“Adults with sickle cell disease can be cured without chemotherapy – the main barrier that has stood in the way for them for so long,” Rondelli said. “Our data provide more support that this therapy is safe and effective and prevents patients from living shortened lives, condemned to pain and progressive complications.”
To learn more about ongoing sickle cell transplant trials at NIH (a participant in a trial will not be charged for a procedure) call 1-800-411-1222 or visit the NIH clinical trials registry at www.clinicaltrials.gov and search under ‘sickle cell disease.”
article by Gwendolyn Harris via blackdoctor.org

The National Academy of Medicine, formerly known as the Institute for Medicine, was founded in 1970. Election to the National Academy of Medicine is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. With the 70 new members, there are now 1,826 active fellows of the National Academy of Medicine along with 137 foreign associates.
An analysis of the list of the 70 new members of the National Academy of Medicine by JBHE finds that five, or 7 percent, are Black.
Evan Dale Abel is the John B. Stokes Chair in Diabetes Research and director of the Fraternal Order of Eagles Diabetes Research Center in the Carver College of Medicine at the University of Iowa. Dr. Abel is a graduate of the University of the West Indies and holds a Ph.D. in physiology from Oxford University in England.
Linda Burnes Bolton is vice president and chief nurse executive at Cedars-Sinai Medical Center in Los Angeles. Dr. Burnes Bolton is a past president of the American Academy of Nursing and the National Black Nurses Association. She is a trustee at Case Western Reserve University. A graduate of Arizona State University, Dr. Burnes Bolton holds two master’s degrees and a doctorate in public health from the University of California, Los Angeles.
Otis Webb Brawley is a professor of hematology, medical oncology, medicine, and epidemiology at Emory University in Atlanta. He is also the chief medical officer for the American Cancer Society in Atlanta. Dr. Brawley earned his medical degree at the University of Chicago.
Melissa Lynn Gilliam is dean for diversity and inclusion and a professor in the department of obstetrics and gynecology and pediatrics at the University of Chicago. Dr. Gilliam is a graduate of Harvard Medical School.
Elizabeth Odilile Ofili is the senior associate dean for clinical and translational research, professor of medicine, and director of the Clinical Research Center at Morehouse School of Medicine in Atlanta. She earned her medical degree at Ahmadu Bello University in Nigeria and a master of public health degree from Johns Hopkins University.
article via jbhe.com
